|
CEO
Namyong Kim Interviewed by GeneWired
The
interview was conducted ‘live’ on 26 December
2009. Interviewee is Dr. Namyong Kim, Chief Executive
Officer of Curiox Biosystems Pte Ltd. More
»
|
| |
April 14,
2010
Curiox
team bags another award Criox
CEO, Dr Namyong Kim, has won the A*STAR Scientist-Entrepreneur
Award for 2010. This recent accomplishment for Curiox
earns the young start-up its third award for the year.
More »
|
| |
March 12,
2010
Curiox
wins Emerging Company of the Year 2010, for biomedical
sciences Curiox
was awarded Emerging Company of the Year 2010 in Asia
Pacific, on 12th March, by BioSpectrum Asia. More
»
|
| |
January 18,
2010
Curiox
receives international and local recognition
Curiox's
DropArray™ Technology chosen as one of
eight promising emerging laboratory automation technologies
in the industry More
»
|
| |
July
27, 2009
Prof.
Alex Matter becomes member of the Board of Directors of
Curiox Biosystems
- Scientist
of international reputation
- Former
Head of Oncology Research at Novartis
- "Curiox
establishes itself"
More »
|
| |
Feb
2009
DropArray™
platform
enables breakthrough clinical research in ophthalmology
Local
spin-off to work with the Singapore eye research institute
(SERI) to develop rapid diagnosis of common eye disease.
More »
|
| |
May
26, 2008
Curiox
Establishes Sales Partnership in Korea with BioBud
Curiox
Biosystems Pte Ltd of Singapore has entered into a sales
partnership agreement with Seoul-based BioBud Inc. covering
the exclusive distribution of the Curiox DropArray™
Products in the Republic of Korea. More
»
|
| |
Dec
17, 2007
Cheaper
Drugs Now Closer to Realization with New DropArray Technology
A
standard laboratory tool for measuring pharmacological
activity of biological substances and performing other
related tests may soon be replaced by a new miniaturized
bioassay that will be faster, cheaper and more efficient
for scientists to use. More
»
|
| |
Dec
17, 2007
Nanostart AG Marks Entry
Into Asia As Lead Investor In Singapore's Biomed Start-Up
Curiox Biosystems Nanostart
AG, the world's leading nanotechnology investment company
based in Germany, is taking an investment position in
Singapore-based Curiox Biosystems, with a 16.5 per cent
investment in the start-up. More
»
|
| |
May
30, 2007
Start-Up@Singapore
Winner Set to Transform Drug Discovery Research
CurioX
Biotech triumphed at the 8th Start-Up@Singapore buysiness
plan competition, taking home the trophy and S$30,000
in prize money. Founded by researchers from the Institute
of Bioengineering and Nanotechnology (IBN) More
»
|
| |
Press
Releases